Humana Inc (HUM) Stake Raised by Hartford Investment Management Co.

Hartford Investment Management Co. raised its holdings in Humana Inc (NYSE:HUM) by 21.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,301 shares of the insurance provider’s stock after purchasing an additional 3,448 shares during the quarter. Hartford Investment Management Co.’s holdings in Humana were worth $5,134,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of HUM. Norges Bank acquired a new position in Humana during the 4th quarter worth $402,117,000. Millennium Management LLC lifted its holdings in Humana by 254.8% during the 4th quarter. Millennium Management LLC now owns 503,066 shares of the insurance provider’s stock worth $144,118,000 after buying an additional 361,263 shares during the last quarter. Ceredex Value Advisors LLC lifted its holdings in Humana by 53.2% during the 4th quarter. Ceredex Value Advisors LLC now owns 726,423 shares of the insurance provider’s stock worth $208,468,000 after buying an additional 252,341 shares during the last quarter. Morgan Stanley lifted its holdings in Humana by 130.5% during the 3rd quarter. Morgan Stanley now owns 368,401 shares of the insurance provider’s stock worth $124,712,000 after buying an additional 208,595 shares during the last quarter. Finally, Calamos Advisors LLC lifted its holdings in Humana by 114.4% during the 1st quarter. Calamos Advisors LLC now owns 306,086 shares of the insurance provider’s stock worth $81,419,000 after buying an additional 163,339 shares during the last quarter. Institutional investors own 94.72% of the company’s stock.

In other Humana news, insider Christopher H. Hunter sold 15,586 shares of the stock in a transaction on Monday, February 25th. The stock was sold at an average price of $305.24, for a total transaction of $4,757,470.64. Following the sale, the insider now owns 28,100 shares in the company, valued at approximately $8,577,244. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.54% of the stock is currently owned by corporate insiders.

A number of analysts have issued reports on HUM shares. SunTrust Banks decreased their price target on Humana to $300.00 in a report on Thursday, May 2nd. Citigroup reduced their target price on Humana from $397.00 to $362.00 and set a “buy” rating for the company in a report on Thursday, February 7th. Morgan Stanley set a $331.00 target price on Humana and gave the company a “buy” rating in a report on Thursday, May 2nd. Zacks Investment Research downgraded Humana from a “buy” rating to a “hold” rating in a report on Friday, February 8th. Finally, UBS Group started coverage on Humana in a research note on Tuesday, April 23rd. They set a “neutral” rating and a $266.00 price objective for the company. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $337.26.

Shares of HUM traded up $3.97 on Wednesday, reaching $260.73. The stock had a trading volume of 2,120,278 shares, compared to its average volume of 1,347,202. The stock has a market cap of $33.46 billion, a P/E ratio of 17.92, a P/E/G ratio of 1.02 and a beta of 0.88. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.65 and a quick ratio of 1.65. Humana Inc has a twelve month low of $225.65 and a twelve month high of $355.88.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, May 1st. The insurance provider reported $4.48 EPS for the quarter, beating analysts’ consensus estimates of $4.30 by $0.18. The firm had revenue of $16.11 billion for the quarter, compared to analysts’ expectations of $15.67 billion. Humana had a return on equity of 20.77% and a net margin of 2.99%. Humana’s quarterly revenue was up 12.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.36 EPS. Research analysts expect that Humana Inc will post 17.57 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, June 27th. Humana’s dividend payout ratio (DPR) is presently 15.12%.

WARNING: This piece was reported by Sundance Herald and is the sole property of of Sundance Herald. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: What is diluted earnings per share (Diluted EPS)?

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with's FREE daily email newsletter.

Leave a Reply